Creative Medical Technology Holdings, Inc.
CELZ
$2.14
$0.052.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 179.40% | -26.25% | |||
| Depreciation & Amortization | -22.87% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 70.20% | -32.06% | |||
| Operating Income | -69.93% | 31.72% | |||
| Income Before Tax | -78.26% | 33.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -78.26% | 33.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -78.26% | 33.23% | |||
| EBIT | -69.93% | 31.72% | |||
| EBITDA | -72.45% | 32.31% | |||
| EPS Basic | -45.74% | 32.60% | |||
| Normalized Basic EPS | -45.75% | 32.61% | |||
| EPS Diluted | -45.74% | 32.60% | |||
| Normalized Diluted EPS | -45.75% | 32.61% | |||
| Average Basic Shares Outstanding | 22.31% | -0.92% | |||
| Average Diluted Shares Outstanding | 22.31% | -0.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||